Literature DB >> 26264631

How a New Health Intervention Affects the Health Systems? Learnings from Pentavalent Vaccine Introduction in India.

Chandrakant Lahariya1,2, Renu Paruthi3, Madhulekha Bhattacharya4.   

Abstract

OBJECTIVES: To summarize the findings from a Post Introduction Evaluation (PIE) of pentavalent vaccine in Tamil Nadu and Kerala state of India and to understand how the health systems could be prepared for (prior to) introducing a new intervention and how such introduction could affect the health systems (afterwards).
METHODS: A post introduction evaluation (PIE) of Haemophilus influenzae type b (Hib) as pentavalent (DPT + HepB + Hib) vaccine was conducted in Tamil Nadu and Kerala states of India in July-Aug 2012. The PIE was conducted as per World Health Organization PIE methods and tools specifically adapted for India. This PIE adopted a 'mixed method approach' with qualitative data focus.
RESULTS: The planning for the introduction of pentavalent vaccine provided opportunities to strengthen various functions of the health system i.e., piloting of Open Vial Policy, strengthening surveillance system, improving Adverse Events Following Immunization (AEFI) reporting system and formation of the technical expert groups. It provided opportunity for bringing attention on the immunization programme in general as well. After the vaccine introduction, the beneficial effects were noted on stewardship (increased oversight by top level policy makers and programme managers), creating resources (investment and trainings of staff in immunization), service delivery (increased coverage with the vaccines and improved quality of services) and financing (increased financial allocation and reduced out of pocket expenditures as more people started attending public health facilities). The vaccine introduction was found to be associated with improvement in the health equity, efficiency and service utilization (effective coverage).
CONCLUSIONS: New vaccine introduction provides opportunities (both before and after) for strengthening the health systems in setting such as India. Preparing the health system for new challenges has potential to strengthen the health systems, if done in well-coordinated and planned manner. Considering that essential steps are largely similar, these lessons could be applicable for the introduction of other new health interventions in the similar settings.

Entities:  

Keywords:  Evaluations; Haemophilus influenzae type b; Health systems; India; Vaccines

Mesh:

Substances:

Year:  2015        PMID: 26264631     DOI: 10.1007/s12098-015-1844-x

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Introducing new vaccines into developing countries: obstacles, opportunities and complexities.

Authors:  John Clemens; Luis Jodar
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

2.  WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-11-24

3.  NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.

Authors: 
Journal:  Indian Pediatr       Date:  2009-11       Impact factor: 1.411

Review 4.  The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

Authors:  Terri B Hyde; Holly Dentz; Susan A Wang; Helen E Burchett; Sandra Mounier-Jack; Carsten F Mantel
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

Review 5.  Introduction of Haemophilus influenzae type b (Hib) as pentavalent(DPT-HepB-Hib) vaccine in two states of India.

Authors:  Satish Kumar Gupta; Stephen Sosler; Chandrakant Lahariya
Journal:  Indian Pediatr       Date:  2012-09       Impact factor: 1.411

Review 6.  New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening.

Authors:  Susan A Wang; Terri B Hyde; Sandra Mounier-Jack; Logan Brenzel; Michael Favin; W Scott Gordon; Jessica C Shearer; Carsten F Mantel; Narendra Arora; David Durrheim
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

7.  An assessment of hepatitis B vaccine introduction in India: Lessons for roll out and scale up of new vaccines in immunization programs.

Authors:  Chandrakant Lahariya; B P Subramanya; Stephen Sosler
Journal:  Indian J Public Health       Date:  2013 Jan-Mar

8.  Universal coverage challenges require health system approaches; the case of India.

Authors:  Antonio Duran; Joseph Kutzin; Nata Menabde
Journal:  Health Policy       Date:  2013-11-25       Impact factor: 2.980

Review 9.  A brief history of vaccines & vaccination in India.

Authors:  Chandrakant Lahariya
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

  9 in total
  2 in total

Review 1.  Learnings from Pentavalent Vaccine Introduction in India.

Authors:  A K Dutta
Journal:  Indian J Pediatr       Date:  2016-02-27       Impact factor: 1.967

Review 2.  Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.

Authors:  Jyoti Joshi; Manoja Kumar Das; Deepak Polpakara; Satinder Aneja; Mahesh Agarwal; Narendra Kumar Arora
Journal:  Indian J Pediatr       Date:  2017-11-23       Impact factor: 5.319

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.